Region:  
 
      Advanced
Search
 
Bookmark and Share 
  
Find An Educational Offering
Select Search Criteria
Keyword:
Events starting on or after:  mm/dd/yyyy
Events Added:
Region:
Interest Areas (IA): Hold the CTRL key to select or de-select multiple items from adjacent list box

     
Event Type: Hold the CTRL key to select or de-select multiple items from adjacent list box

 
 
  Click here to Expand the Tab 
10105 2nd Joint DIA/ European Medicines Agency Innovation Forum: Is the EU Regulatory Framework Ready?
 Overview 
 Agenda / Committee 
 Continuing Education 
 Tutorial / Sub-Events 
 Exhibits 
 Travel/Hotel Information 
 Registration Fees 
 Related Offerings 
 Highlights 
Title:
2nd Joint DIA/ European Medicines Agency Innovation Forum: Is the EU Regulatory Framework Ready?


Date(s) And Time(s):
Nov 29 2010 7:00AM - Nov 30 2010 4:15PM

Location:
Marriott West India Quay
22 Hertsmere Rd, Canary Wharf
London
E14 4ED
United Kingdom

Interest Area(s):
CMC,Quality Assurance/Quality Control,Regulatory Affairs,Research & Development,Clinical Research,Manufacturing

Overview:

The 2nd Innovation forum will provide an opportunity to address the progress of innovative medicines in legal, organisational and technical aspects of the pharmaceutical framework in Europe. It will address the implementation of the EMA/CHMP think-tank report on innovative medicines and look at the direction of the Agency’s road map 2015. This forum will involve stakeholders such as patient representatives, academia delegates, regulators and industry scientists.

Key Topics
• Current activities at EU level to ensure innovation in science translates into benefit for the patients and to public health. This includes the new pharmaceutical package, paediatric medicines, gene therapy and stem cells, information to patients and European Commission impact assessment of the clinical trial directive

• Impact of the implementation of the 2007 think-tank report on the European Medicines Agency activities and road map to 2015 to support enhanced regulatory decision-making and access to medicines

• Innovation in the pharmaceutical industry: Looking for examples of innovative approaches in portfolio selection for R&D strategy

• The availability of innovative medicines and unmet medical needs: Role of regulators and policy makers

• Progress with IMI



Target Audience:

• Patient Groups
• Health Authorities
• Policy Makers
• Pharmaceutical Industry



Event Code:
10105

Contact Information:
DIA EUROPE

ELISABETHENANLAGE 25, POSTFACH

4002 BASEL, SWITZERLAND

PHONE: +41 61 225 51 51

FAX: +41 61 225 51 52

E-MAIL: DIAEUROPE@DIAEUROPE.ORG